A perspective on the use of polyphenols nano-formulation as a nutritional strategy to manage the symptoms of the infected patient with COVID-19
DOI:
https://doi.org/10.33448/rsd-v10i13.21471Keywords:
Nanotechnology; Bioactive ingredients; Functional food; Coronaviruses; Curcumin.Abstract
Coronaviruses disease (COVID-19) vaccines have emerged worldwide to control this illness, albeit they cannot guarantee full effectiveness. Polyphenols possess antioxidant, anti-inflammatory, and antiviral properties, all of which may be effective against COVID-19 symptoms. Since polyphenols exhibit low bioavailability, polyphenols nano-formulation (a food technology) have been utilized in COVID-19 patients. Therefore, the purpose of this review is to discuss the current evidence showing the effects of polyphenols nano-formulation in COVID-19 patients. Two previous studies have demonstrated that polyphenols nano-formulation (particularly curcumin) can alleviate clinical manifestation (fever, tachypnea, myalgia, cough) and improve overall recovery since polyphenols can modulate the inflammatory response, oxidative stress, and upregulate certain proteins involved in the renin-angiotensin system, all which play a crucial role on the symptoms caused by COVID-19.
References
Annunziata, G., Maisto, M., Schisano, C., Ciampaglia, R., Narciso, V., Tenore, G. C., & Novellino, E. (2018). Resveratrol as a novel anti-herpes simplex virus nutraceutical agent: an overview. Viruses, 10(9), 473.
Annunziata, G., Sanduzzi Zamparelli, M., Santoro, C., Ciampaglia, R., Stornaiuolo, M., Tenore, G. C., & Novellino, E. (2020). May polyphenols have a role against coronavirus infection? An overview of in vitro evidence. Frontiers in Medicine, 7, 240.
Babaei, F., Nassiri‐Asl, M., & Hosseinzadeh, H. (2020). Curcumin (a constituent of turmeric): New treatment option against COVID‐19. Food science & nutrition, 8(10), 5215-5227.
Chojnacka, K., Witek-Krowiak, A., Skrzypczak, D., Mikula, K., & Młynarz, P. (2020). Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. Journal of Functional Foods, 104146.
De Leo, A., Arena, G., Lacanna, E., Oliviero, G., Colavita, F., & Mattia, E. (2012). Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets. Antiviral Research, 96(2), 196-202.
de Oliveira, G. V., Volino-Souza, M., Conte-Júnior, C. A., & Alvares, T. S. (2021). Food-derived polyphenol compounds and cardiovascular health: a nano-technological perspective. Food Bioscience, 101033.
Faith, S. A., Sweet, T. J., Bailey, E., Booth, T., & Docherty, J. J. (2006). Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells. Antiviral Research, 72(3), 242-251.
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS journal, 15(1), 195-218.
Hamming, I., Timens, W., Bulthuis, M. L. C., Lely, A. T., Navis, G. V., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 203(2), 631-637.
Hanuka Katz, I., Eran Nagar, E., Okun, Z., & Shpigelman, A. (2020). The Link between polyphenol structure, antioxidant capacity and shelf-life stability in the presence of fructose and ascorbic acid. Molecules, 25(1), 225.
Levy, E., Delvin, E., Marcil, V., & Spahis, S. (2020). Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?. American Journal of Physiology-Endocrinology and Metabolism, 319(4), E689-E708.
Li, H., Wu, J., Zhang, Z., Ma, Y., Liao, F., Zhang, Y., & Wu, G. (2011). Forsythoside a inhibits the avian infectious bronchitis virus in cell culture. Phytotherapy Research, 25(3), 338-342.
Lin, C. J., Lin, H. J., Chen, T. H., Hsu, Y. A., Liu, C. S., Hwang, G. Y., & Wan, L. (2015). Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS One, 10(2), e0117602.
Lin, S. C., Ho, C. T., Chuo, W. H., Li, S., Wang, T. T., & Lin, C. C. (2017). Effective inhibition of MERS-CoV infection by resveratrol. BMC Infectious Diseases, 17(1), 1-10.
Liu, T., Zang, N., Zhou, N., Li, W., Xie, X., Deng, Y., & Liu, E. (2014). Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection. Journal of Virology, 88(8), 4229-4236.
Manach, C., Scalbert, A., Morand, C., Rémésy, C., & Jiménez, L. (2004). Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition, 79(5), 727-747.
Pang, X. F., Zhang, L. H., Bai, F., Wang, N. P., Garner, R. E., McKallip, R. J., & Zhao, Z. Q. (2015). Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug design, development and therapy, 9, 6043.
Roh, C. (2012). A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. International Journal of Nanomedicine, 7, 2173.
Saber‐Moghaddam, N., Salari, S., Hejazi, S., Amini, M., Taherzadeh, Z., Eslami, S., & Elyasi, S. (2021). Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial. Phytotherapy Research.
Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T., & Morimoto, T. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin, 34(5), 660-665.
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 117(21), 11727-11734.
Soni, V. K., Mehta, A., Ratre, Y. K., Tiwari, A. K., Amit, A., Singh, R. P., & Vishvakarma, N. K. (2020). Curcumin, a traditional spice component, can hold the promise against COVID-19? European Journal of Pharmacology, 173551.
Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Gencer, M. Z., Ammari, A., Sadeghi, A., & Ahmadi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89, 107088.
Volino-Souza, M., de Oliveira, G. V., Conte-Junior, C. A., & Alvares, T. S. (2020). Covid-19 quarantine: impact of lifestyle behaviors changes on endothelial function and possible protective effect of beetroot juice. Frontiers in Nutrition, 7.
Yiu, C. Y., Chen, S. Y., Chang, L. K., Chiu, Y. F., & Lin, T. P. (2010). Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle. Molecules, 15(10), 7115-7124.
Zang, N., Xie, X., Deng, Y., Wu, S., Wang, L., Peng, C., & Liu, E. (2011). Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. Journal of Virology, 85(24), 13061-13068.
Zhang, L., Li, Y., Gu, Z., Wang, Y., Shi, M., Ji, Y., & Shi, W. (2015). Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway. PloS One, 10(2), e0116879.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Tan, W. (2020). China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8), 727-733.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gustavo Vieira de Oliveira; Mônica Volino-Souza; Karen Souza dos Santos; Yunes Scarpine Malheiros; Carlos Adam Conte-Júnior; Thiago Silveira Alvares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
